Seed VC · Gijon, Spain

Waarde Capital

Active

What they invest in

Waarde Capital is a private investment firm based in Amsterdam, Netherlands, specializing in venture capital and private equity investments. Established in 2013, the firm focuses on supporting early-stage and growth-stage companies across various sectors, including technology, consumer goods, and healthcare. Waarde Capital is known for its hands-on approach, working closely with portfolio companies to drive growth and operational excellence. The firm has built a reputation for fostering innovation and sustainable business practices within its investments.

Who they back

AviationDigital InfrastructureMarketplaceClean EnergyHydrogen Fuel CellseVTOLSeedSeries A

Business models

saas_b2b, marketplace, hardware, platform, deeptech_ip, biotech_therapeutics

Customer segments

Enterprise, SMB, Consumer, Developers

Geography

Europe, US, Israel, Africa, APAC

Recent investments

  • ZeroAvia
  • SABI
  • Max.ng

+ 3 more deals. Score your deck to see the full investment history.

We never publish partner emails directly — score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Waarde Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. Claude Fundraiser tracks Waarde Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
Spain
Website
www.waardecapital.com
LinkedIn
Firm profile ↗

Other firms investing in Aviation

See all investors →

Is Waarde Capital the right fit for your deck?

Drop your pitch. Claude scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Waarde Capital is one of them — and we'll tell you exactly where they sit in your top 100.